Nothing Special   »   [go: up one dir, main page]

Gans, 1966 - Google Patents

Thrombogenic properties of epsilon amino caproic acid

Gans, 1966

View PDF
Document ID
2180100943568749003
Author
Gans H
Publication year
Publication venue
Annals of Surgery

External Links

Snippet

Materials and Methods Healthy mongrel dogs, weighing from l6 to 205 Kg., were anesthetized using Nembutal Sodium, l ml. per 25 Kg. body weight. Polyethylene catheters (15 gauge) were introduced into the femoral vein and femoral artery. A three-way stopcock …
Continue reading at www.ncbi.nlm.nih.gov (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation; Extra-corporeal blood circuits
    • A61M1/3601—Extra-corporeal circuits in which the blood fluid passes more than once through the treatment unit
    • A61M1/3603—Extra-corporeal circuits in which the blood fluid passes more than once through the treatment unit in the same direction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application

Similar Documents

Publication Publication Date Title
Flick et al. Leukocytes are required for increased lung microvascular permeability after microembolization in sheep.
Swartz et al. Preventing hemorrhage in high-risk hemodialysis: regional versus low-dose heparin
Horrow et al. Prophylactic tranexamic acid decreases bleeding after cardiac operations
de Haan et al. Retransfusion of suctioned blood during cardiopulmonary bypass impairs hemostasis
Del Rossi et al. Prophylactic treatment of postperfusion bleeding using EACA
Kang et al. Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation
Kobrinsky et al. Shortening of bleeding time by 1-deamino-8-D-arginine vasopressin in various bleeding disorders
BAKER et al. Hypofibrinogenemic hemorrhage in acute myelogenous leukemia treated with heparin: with autopsy findings of widespread intravascular clotting
Gold et al. Coronary thrombolysis with recombinant human tissue-type plasminogen activator.
JPH06100454A (en) Medicine for improving flow of blood and oxygen addition of tumor
Gans Thrombogenic properties of epsilon amino caproic acid
Walenga et al. Potential use of recombinant hirudin as an anticoagulant in a cardiopulmonary bypass model
JPH0292363A (en) Method for preventing formation of blood clot
Tibballs et al. The cardiovascular and haematological effects of purified prothrombin activator from the common brown snake (Pseudonaja textilis) and their antagonism with heparin
Axford et al. Safety and therapeutic effectiveness of reinfused shed blood after open heart surgery
Halmagyi et al. The lung as the main target organ in the acute phase of transfusion reaction in sheep
Douglas et al. Thrombolytic therapy
Schneider Release of anticoagulant during shock of experimental meconium embolism
JPH08208504A (en) Use of vwf-containing concentrate as medical treatment applied by combining with anti-thrombotic and thrombus-dissolving medical treatment
Ekert et al. Fibrinolysis during extracorporeal circulation: comparison of the effects of disc and membrane oxygenators
Borg et al. Complement activation and its relationship to adult respiratory distress syndrome. An experimental study in pigs
Malviya Monitoring and management of anticoagulation in children requiring extracorporeal circulation
Ashouri Regional sodium citrate anticoagulation in patients with active bleeding undergoing hemodialysis
Strautz et al. Compatibility of ADSOL-stored red cells with intravenous solutions
Terrell et al. Efficacy of aprotinin with various anticoagulant agents in cardiopulmonary bypass